Acquisitions29 Sept 2025, 10:03 pm
Camlin Fine Sciences to Acquire Majority Stake in Vinpai for €3.60 per Share, Issuing New Shares Worth €101.7 Million
AI Summary
Camlin Fine Sciences Ltd. has announced a definitive timetable for its shareholders meeting to issue new shares for the block acquisition in Vinpai. The Indian group in shelf life solutions for flavour and health & wellness ingredients has entered into a binding agreement with the majority shareholders of Vinpai for the acquisition of a majority stake and the issuance of convertible bonds. The Block Acquisition is subject to the opening of DEMAT accounts by the Sellers to receive the CFSL Consideration Shares. The Board of Directors of CFSL has initiated the process to obtain CFSL shareholders’ approval to the issuance of CFSL Consideration Shares via postal ballot.
Key Highlights
- Camlin Fine Sciences to acquire majority stake in Vinpai for €3.60 per share
- Issuance of convertible bonds to finance Vinpai's business
- Sellers to hold 78.68% of Vinpai's share capital and 83.73% of its voting rights post-acquisition
- CFSL shareholders’ approval required for the issuance of CFSL Consideration Shares
- DEMAT accounts to be opened by the Sellers to receive CFSL Consideration Shares